Ultromics is a series b startup based in United Kingdom. 5 investors tracked.
Based in the United Kingdom, Ultromics is a startup founded in 2016. Its most recent tracked round is Series-c-plus. Brouky records 3 investors associated with the company.
Ultromics develops AI-powered diagnostic tools that analyze echocardiograms to identify complex cardiac diseases, including heart failure and cardiac amyloidosis, enabling earlier and more accurate diagnoses.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.